<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-205-9-39-45</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Карта прогноза рака желудка - основа для формирования регистра больных с предраковыми заболеваниями</article-title><trans-title-group xml:lang="en"><trans-title>The stomach cancer prognosis map is the basis for the formation of a register of patients with precancerous diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9134-931X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барановский</surname><given-names>Андрей Юрьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Baranovsky</surname><given-names>A. Yu.</given-names></name></name-alternatives><email xlink:type="simple">baranovsky46@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6684-0422</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цветкова</surname><given-names>Татьяна Лазаревна</given-names></name><name name-style="western" xml:lang="en"><surname>Tsvetkova</surname><given-names>T. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Saint Petersburg State University”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Новел СПб»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novel SPb LLC</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>9</issue><fpage>39</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Барановский А.Ю., Цветкова Т.Л., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Барановский А.Ю., Цветкова Т.Л.</copyright-holder><copyright-holder xml:lang="en">Baranovsky A.Y., Tsvetkova T.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2037">https://www.nogr.org/jour/article/view/2037</self-uri><abstract><p>Проведено одномоментное ретроспективное обсервационное сравнительное исследование, для поиска наиболее значимых факторов риска рака желудка. Проведен анализ 36 факторов риска рака желудка у 143 больных в возрасте от 32 до 83 лет, коренных жителей городов, областей и республик СЗФО России, перенесших комплексное, в том числе хирургическое лечение данного заболевания. Группу контроля составили 128 человек, проходивших углубленную диспансеризацию в объеме, необходимом для программы настоящего исследования. Ранжир изученных факторов риска рака желудка по их степени прогностической значимости представлен следующим образом: наличие предраковых заболеваний, сопровождающихся прогрессирующей атрофией слизистой оболочки желудка, кишечной метаплазией и/или дисплазией в сочетании с длительным желудочным хеликобактериозом; снижение в крови содержания пепсиногена I и стимулированного гастрина-17, а также снижение соотношения PG I/PG II; продолжительное наличие анемии, лейкопении, нейтропении, лимфопении, тромбоцитопении, особенно у больных мужчин старше 50 лет с вредными привычками (курение, злоупотребление алкоголем); наличие у больных сахарного диабета и ожирения, особенно при их сочетании и при условии повышенного показателя гликозированного гемоглобина; грубые и множественные нарушения ритма питания и содержания пищевого рациона. Использование полученных данных может быть проведена математическая оценка прогностической значимости каждого из изученных признаков, разработан алгоритм прогноза рака желудка и принятия индивидуализированных медицинских решений, без которых невозможно создать эффективный и удобный в работе на всех этапах медицинской помощи регистр больных с предраковыми заболеваниями для организации и проведения персонифицированных и действенных мероприятий канцеропревенции.</p></abstract><trans-abstract xml:lang="en"><p>A single-stage retrospective observational comparative study was conducted to find the most significant risk factors for stomach cancer. The analysis of 36 risk factors for stomach cancer in 143 patients aged 32 to 83 years, indigenous residents of cities, regions and republics of the Northwestern Federal District of Russia who underwent complex, including surgical treatment of this disease. The control group consisted of 128 people who underwent in-depth medical examination in the amount necessary for the program of this study. The ranking of the studied risk factors for gastric cancer according to their degree of prognostic significance is presented as follows: the presence of precancerous diseases accompanied by progressive atrophy of the gastric mucosa, intestinal metaplasia and/or dysplasia in combination with prolonged gastric helicobacteriosis; a decrease in the blood content of pepsinogen I and stimulated gastrin-17, as well as a decrease in the ratio of PG I/PG II; prolonged presence of anemia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, especially in men over 50 years of age with bad habits (smoking, alcohol abuse); presence in patients with diabetes mellitus and obesity, especially when combined with them and under the condition of an increased index of glycosed hemoglobin; gross and multiple disorders of the rhythm of nutrition and the content of the diet. Using the obtained data, a mathematical assessment of the prognostic significance of each of the studied signs can be carried out, an algorithm for predicting stomach cancer and making individualized medical decisions is developed, without which it is impossible to create an effective and convenient register of patients with precancerous diseases at all stages of medical care for organizing and conducting personalized and effective cancer prevention measures.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>прогноз рака желудка</kwd><kwd>факторы риска</kwd><kwd>предраковые заболевания желудка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>prognosis of stomach cancer</kwd><kwd>risk factors</kwd><kwd>precancerous diseases of the stomach</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Scientific Reports. 2019. 9(1):1-9. doi: 10.1038/s41598-019-48769</mixed-citation><mixed-citation xml:lang="en">Taninaga J., Nishiyama Y., Fujibayashi K., et al. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Scientific Reports. 2019. 9(1):1-9. doi: 10.1038/s41598-019-48769</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Milano A. F. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration &amp; Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4). J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1.</mixed-citation><mixed-citation xml:lang="en">Milano A. F. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration &amp; Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4). J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R. L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R. L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007. 10(2):75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation><mixed-citation xml:lang="en">Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007. 10(2):75-83. doi: 10.1007/s10120-007-0420-0.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Q., Zhu C., Yuan Y., et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019. 68(9):1576-1587. doi: 10.1136/gutjnl-2018-317556.</mixed-citation><mixed-citation xml:lang="en">Cai Q., Zhu C., Yuan Y., et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019. 68(9):1576-1587. doi: 10.1136/gutjnl-2018-317556.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tu H., Sun L., Dong X., et al. А Serological Biopsy Using Five Stomach-Specific circulating Biomarkers for gastric cancer risk assessment: a Multi-Phase Study. Am J Gastroenterol. 2017. 112(5):704-715. doi:10.1038/ajg.2017.55.</mixed-citation><mixed-citation xml:lang="en">Tu H., Sun L., Dong X., et al. А Serological Biopsy Using Five Stomach-Specific circulating Biomarkers for gastric cancer risk assessment: a Multi-Phase Study. Am J Gastroenterol. 2017. 112(5):704-715. doi:10.1038/ajg.2017.55.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Q., Yu E. D., Xiao Y., et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk chinese. Am J Epidemiol. 2012; 175:584-93. doi: 10.1093/aje/kwr337.</mixed-citation><mixed-citation xml:lang="en">Cai Q., Yu E. D., Xiao Y., et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk chinese. Am J Epidemiol. 2012; 175:584-93. doi: 10.1093/aje/kwr337.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rawla P., Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019; 14(1): 26-38. doi: 0.5114/pg.2018.80001.</mixed-citation><mixed-citation xml:lang="en">Rawla P., Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019; 14(1): 26-38. doi: 0.5114/pg.2018.80001.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ilson, D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2017;(33): 473-476. doi: 10.1097/MOG.0000000000000395.</mixed-citation><mixed-citation xml:lang="en">Ilson, D. H. Advances in the treatment of gastric cancer. Curr. Opin. Gastroenterol. 2017;(33): 473-476. doi: 10.1097/MOG.0000000000000395.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer, 2016. Revised 2018. Available at: https://www.aicr.org/wp-content/uploads/2020/01/stomach-cancer-report.pdf Access 05/05/2020.</mixed-citation><mixed-citation xml:lang="en">World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer, 2016. Revised 2018. Available at: https://www.aicr.org/wp-content/uploads/2020/01/stomach-cancer-report.pdf Access 05/05/2020.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Alimentary pharmacology and therapeutics. 2013. No. 37, pp. 375-382. doi: 10.1111/apt.12177.</mixed-citation><mixed-citation xml:lang="en">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Alimentary pharmacology and therapeutics. 2013. No. 37, pp. 375-382. doi: 10.1111/apt.12177.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-1877. doi: 10.1001/archinte.166.17.1871.</mixed-citation><mixed-citation xml:lang="en">Inoue M., Iwasaki M., Otani T., et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Archives of internal medicine. 2006, no. 166, pp. 1871-1877. doi: 10.1001/archinte.166.17.1871.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. European journal of cancer. 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation><mixed-citation xml:lang="en">Yang P., Zhou Y., Chen B., et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. European journal of cancer. 2009, no. 45, pp. 2867-2873. doi: 10.1016/j.ejca.2009.04.019.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kim G. H., Liang P. S., Bang S. J., et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal Endosc. 2016 Jul;84(1):18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation><mixed-citation xml:lang="en">Kim G. H., Liang P. S., Bang S. J., et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointestinal Endosc. 2016 Jul;84(1):18-28. doi: 10.1016/j.gie.2016.02.028.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">by M. D. DeVita, Vincent T., Jr (Editor), Ph. D. Lawrence, Theodore S., M.D. (Editor), Steven A. Rosenberg (Editor) DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology (Cancer: Principles &amp; Practice (DeVita) 10th Edition. Publisher: Lippincott Williams &amp; Wilkins; 10th edition, 2021.</mixed-citation><mixed-citation xml:lang="en">by M. D. DeVita, Vincent T., Jr (Editor), Ph. D. Lawrence, Theodore S., M.D. (Editor), Steven A. Rosenberg (Editor) DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology (Cancer: Principles &amp; Practice (DeVita) 10th Edition. Publisher: Lippincott Williams &amp; Wilkins; 10th edition, 2021.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">AlipourM. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021 Mar;52(1):23-30. doi: 10.1007/s12029-020-00518-5.</mixed-citation><mixed-citation xml:lang="en">AlipourM. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021 Mar;52(1):23-30. doi: 10.1007/s12029-020-00518-5.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Xu C. X., Gong R. J., et al. How does Helicobacter pylori cause gastric cancer through connexins: An opinion review. World J Gastroenterol. 2019 Sep 21;25(35):5220-5232. doi: 10.3748/wjg.v25.i35.5220.</mixed-citation><mixed-citation xml:lang="en">Li H., Xu C. X., Gong R. J., et al. How does Helicobacter pylori cause gastric cancer through connexins: An opinion review. World J Gastroenterol. 2019 Sep 21;25(35):5220-5232. doi: 10.3748/wjg.v25.i35.5220.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Karimi P., Islami F., Anandasabapathy S., et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-13. doi: 10.1158/1055-9965.EPI-13-1057.</mixed-citation><mixed-citation xml:lang="en">Karimi P., Islami F., Anandasabapathy S., et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-13. doi: 10.1158/1055-9965.EPI-13-1057.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">González C. A., Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go.Int J Cancer. 2012; 130:745-53. doi: 10.1002/ijc.26430.</mixed-citation><mixed-citation xml:lang="en">González C. A., Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go.Int J Cancer. 2012; 130:745-53. doi: 10.1002/ijc.26430.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou J., Zhou Y., Cao S. Multivariate logistic regression analysis of postoperative complications and risk model establishment of gastrectomy for gastric cancer: A single-center cohort report. Scand J Gastroenterol. 2016 Jan;51(1):8-15. doi: 10.3109/00365521.2015.1063153.</mixed-citation><mixed-citation xml:lang="en">Zhou J., Zhou Y., Cao S. Multivariate logistic regression analysis of postoperative complications and risk model establishment of gastrectomy for gastric cancer: A single-center cohort report. Scand J Gastroenterol. 2016 Jan;51(1):8-15. doi: 10.3109/00365521.2015.1063153.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S. R., Kim K., Lee S. A., et al. Effect of Red, Processed, and White Meat Consumption on the Risk of Gastric Cancer: An Overall and Dose-Response Meta-Analysis. Nutrients. 2019 Apr 11;11(4):826. doi: 10.3390/nu11040826.</mixed-citation><mixed-citation xml:lang="en">Kim S. R., Kim K., Lee S. A., et al. Effect of Red, Processed, and White Meat Consumption on the Risk of Gastric Cancer: An Overall and Dose-Response Meta-Analysis. Nutrients. 2019 Apr 11;11(4):826. doi: 10.3390/nu11040826.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jin G., Lv J., Yang M., Wang M., et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1378-1386. doi: 10.1016/S1470-2045(20)30460-5.</mixed-citation><mixed-citation xml:lang="en">Jin G., Lv J., Yang M., Wang M., et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1378-1386. doi: 10.1016/S1470-2045(20)30460-5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tu H., Sun L., Dong X., et al. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017 May;112(5):704-715. doi: 10.1038/ajg.2017.55.</mixed-citation><mixed-citation xml:lang="en">Tu H., Sun L., Dong X., et al. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017 May;112(5):704-715. doi: 10.1038/ajg.2017.55.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Zhang M., Luo R., et al. Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong. China J Int Med Res. 2021 Feb;49(2):300060521990495. doi: 10.1177/0300060521990495</mixed-citation><mixed-citation xml:lang="en">Liu X., Zhang M., Luo R., et al. Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong. China J Int Med Res. 2021 Feb;49(2):300060521990495. doi: 10.1177/0300060521990495</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Botran R., Wellmann I. A., Une C., еt al. Seroprevalence of Helicobacter pylori/CagA Antibodies in Guatemalan Gastric Cancer Patients: Association of Seropositivity with Increased Plasma Levels of Pepsinogens but not Soluble Urokinase Plasminogen Activator Receptor. Am J Trop Med Hyg. 2020 Jul;103(1):260-265. doi: 10.4269/ajtmh.19-0934.</mixed-citation><mixed-citation xml:lang="en">Fernandez-Botran R., Wellmann I. A., Une C., еt al. Seroprevalence of Helicobacter pylori/CagA Antibodies in Guatemalan Gastric Cancer Patients: Association of Seropositivity with Increased Plasma Levels of Pepsinogens but not Soluble Urokinase Plasminogen Activator Receptor. Am J Trop Med Hyg. 2020 Jul;103(1):260-265. doi: 10.4269/ajtmh.19-0934.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Poorolajal J., Moradi L., Mohammadi Y., et. al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42: e2020004. doi: 10.4178/epih.e2020004.</mixed-citation><mixed-citation xml:lang="en">Poorolajal J., Moradi L., Mohammadi Y., et. al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42: e2020004. doi: 10.4178/epih.e2020004.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold M., Abnet C. C., Neale R. E., Vignat J., et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068.</mixed-citation><mixed-citation xml:lang="en">Arnold M., Abnet C. C., Neale R. E., Vignat J., et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Camilleri M., Malhi H., Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May;152(7):1656-1670. doi: 10.1053/j.gastro.2016.12.052.</mixed-citation><mixed-citation xml:lang="en">Camilleri M., Malhi H., Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May;152(7):1656-1670. doi: 10.1053/j.gastro.2016.12.052.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Patel A. V., Friedenreich C. M., Moore S. C., et al. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc. 2019 Nov;51(11):2391-2402. doi: 10.1249/MSS.0000000000002117.</mixed-citation><mixed-citation xml:lang="en">Patel A. V., Friedenreich C. M., Moore S. C., et al. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc. 2019 Nov;51(11):2391-2402. doi: 10.1249/MSS.0000000000002117.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hirahara T., Arigami T., Yanagita S., et al.Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019 Jul 8;19(1):672. doi: 10.1186/s12885-019-5903-y.</mixed-citation><mixed-citation xml:lang="en">Hirahara T., Arigami T., Yanagita S., et al.Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019 Jul 8;19(1):672. doi: 10.1186/s12885-019-5903-y.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Song H., Ekheden I. G., Zheng Z., et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015 Jul 27;351: h3867. doi: 10.1136/bmj.h3867.</mixed-citation><mixed-citation xml:lang="en">Song H., Ekheden I. G., Zheng Z., et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015 Jul 27;351: h3867. doi: 10.1136/bmj.h3867.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Song H., Ekheden I. G., Ploner A., et al. Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study.Int J Epidemiol. 2018 Apr 1;47(2):440-449. doi: 10.1093/ije/dyx238.</mixed-citation><mixed-citation xml:lang="en">Song H., Ekheden I. G., Ploner A., et al. Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study.Int J Epidemiol. 2018 Apr 1;47(2):440-449. doi: 10.1093/ije/dyx238.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dong E., Chen Q., Chen W. et al. Stomach Cancer Prediction Model (SCoPM) The American Journal of Gastroenterology. 2021 October, Volume 116, Issue, pp. S656-S657. doi: 10.14309/01.ajg.0000779248.99245.30</mixed-citation><mixed-citation xml:lang="en">Dong E., Chen Q., Chen W. et al. Stomach Cancer Prediction Model (SCoPM) The American Journal of Gastroenterology. 2021 October, Volume 116, Issue, pp. S656-S657. doi: 10.14309/01.ajg.0000779248.99245.30</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
